Ticker Details
Curis, Inc. Curis Inc is a biotechnology company engaged in developing and commercializing drug candidates for the treatment of human cancers. Its pipeline products include CUDC-907, CA-170, CA-4948, CA-327, and Erivedge.
IPO Date:	August 1, 2000
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$20.39M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.11 | 3.60%
Avg Daily Range (30 D):	$0.03 | 4.01%
Avg Daily Range (90 D):	$0.04 | 3.73%

Institutional Daily Volume
Avg Daily Volume:	.21M
Avg Daily Volume (30 D):	.27M
Avg Daily Volume (90 D):	.41M

Trade Size
Avg Trade Size (Sh.):	81
Avg Trade Size (Sh.) (30 D):	232
Avg Trade Size (Sh.) (90 D):	308

Institutional Trades
Total Institutional Trades:	619
Avg Institutional Trade:	$1.7M
Avg Institutional Trade (30 D):	$1.07M
Avg Institutional Trade (90 D):	$1.07M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.22M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	16.83K

News

Mar 19, 2026 @ 9:17 PM Curis (CRIS) Q4 2025 Earnings Call Transcript Source: Motley Fool Transcribing

Aug 5, 2025 @ 10:10 PM Curis (CRIS) Q2 Loss Narrows 66% Source: Jesterai

Jul 11, 2024 @ 10:09 AM VISTA Inhibitor Clinical Trials Drug Approval Insi... Source: Kuick Research

Apr 12, 2024 @ 12:34 PM Top 3 Health Care Stocks That May Collapse In Q2 Source: Avi Kapoor

Apr 5, 2024 @ 12:43 PM Strength Seen in Curis (CRIS): Can Its 19.5% Jump ... Source: Zacks Equity Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.58	$1.61	$-.58
Diluted EPS	$-.58	$1.61	$-.58
Revenue	$9.44M	$1.14M	$9.44M
Gross Profit
Net Income / Loss	$-7.58M	$19.36M	$-7.58M
Operating Income / Loss	$-5.71M	$19.62M	$-5.71M
Cost of Revenue
Net Cash Flow	$-14.94M	$-14.94M	$-14.94M
PE Ratio

Splits
Sep 29, 2023	1:20
May 30, 2018	1:5